Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership173,137 shares
Latest Disclosed Value $ 26,446,677
Qube Research & Technologies Ltd ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 173,137 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $26,446,677 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 118,627 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 45.95% during the quarter. The current value of the position is $24,872,861 USD.

Qube Research & Technologies Ltd has a history of taking positions in derivatives of the underlying security (NVS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 500 of underlying shares valued at $76,375 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NVS / Novartis AG - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 173,137 54,510 45.95 26,447 61.70 0.0294
2026-02-17 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 118,627 -70,840 -37.39 16,355 -32.69 0.0166
2025-11-14 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 189,467 189,467 24,297 0.0251
2025-08-14 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -39,723 -100.00 0 -100.00
2025-05-15 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 39,723 -594,851 -93.74 4,428 -92.83 0.0051
2025-02-14 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 634,574 476,420 301.24 61,750 239.47 0.0810
2024-11-14 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 158,154 -17,329 -9.88 18,191 -2.63 0.0268
2024-08-14 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 175,483 -554,229 -75.95 18,682 -73.53 0.0295
2024-05-14 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 729,712 385,402 111.93 70,585 103.04 0.1119
2024-02-13 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 344,310 226,515 192.30 34,765 189.75 0.0677
2023-11-13 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 117,795 -87,989 -42.76 11,999 -42.22 0.0313
2023-08-14 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 205,784 205,784 20,766 0.0755
2023-05-15 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -165,124 -100.00 0 -100.00
2023-02-14 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 165,124 49,736 43.10 14,980 70.79 0.0802
2022-11-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 115,388 -70,151 -37.81 8,771 -44.08 0.0522
2022-08-15 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 185,539 141,326 319.65 15,684 304.23 0.1157
2022-05-09 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 44,213 44,213 3,880 0.0329
2022-02-10 2021-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 0 -103,144 -100.00 0 -100.00
2022-02-01 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -103,144 0
2021-11-12 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 103,144 -1,080 -1.04 8,435 -11.29 0.1058
2021-08-13 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 104,224 101,518 3,751.59 9,509 4,016.45 0.1084
2021-05-14 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,706 2,706 231 0.0037
2021-02-16 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -69,165 -100.00 0 -100.00
2020-11-12 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 69,165 51,907 300.77 6,015 299.14 0.0858
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 17,258 17,258 1,507 0.0221
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -14,829 -100.00 0 -100.00
2020-02-13 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 14,829 14,829 1,404 0.0441
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F NOVARTIS SPONSORED ADR Call 200 0.00 28 8.00 n/a n/a n/a
2025-11-14 2025-09-30 13F NOVARTIS SPONSORED ADR Call 200 -50.00 26 -47.92 n/a n/a n/a
2025-08-14 2025-06-30 13F NOVARTIS SPONSORED ADR Call 400 -81.82 48 -80.41 n/a n/a n/a
2025-05-15 2025-03-31 13F NOVARTIS SPONSORED ADR Call 2,200 -31.25 245 -21.22 n/a n/a n/a
2025-02-14 2024-12-31 13F NOVARTIS SPONSORED ADR Call 3,200 88.24 311 59.49 n/a n/a n/a
2024-11-14 2024-09-30 13F NOVARTIS SPONSORED ADR Call 1,700 196 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR Put 500 -77.27 76 -74.92 n/a n/a n/a
2026-02-17 2025-12-31 13F NOVARTIS SPONSORED ADR Put 2,200 -26.67 303 -21.09 n/a n/a n/a
2025-11-14 2025-09-30 13F NOVARTIS SPONSORED ADR Put 3,000 -18.92 385 -14.09 n/a n/a n/a
2025-08-14 2025-06-30 13F NOVARTIS SPONSORED ADR Put 3,700 32.14 448 43.27 n/a n/a n/a
2025-05-15 2025-03-31 13F NOVARTIS SPONSORED ADR Put 2,800 180.00 312 221.65 n/a n/a n/a
2025-02-14 2024-12-31 13F NOVARTIS SPONSORED ADR Put 1,000 400.00 97 321.74 n/a n/a n/a
2024-11-14 2024-09-30 13F NOVARTIS SPONSORED ADR Put 200 23 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.